Image courtesy of "123rf.com.cn"
Zhiyun Health recently received a strategic investment of approximately RMB 100 million from Tianyi Investment Group. This is another round of financing announced by Zhiyun Health after October last year.
Zhiyun Health is the original “Handheld Sugar Medicineâ€, which was established in December 2014. On November 8th, at the Tencent Global Partner Conference in 2017, Palm Sugar Medical officially announced the release of its parent brand Zhiyun Group, and integrated its business, and announced that it will enter the field of chronic disease and health from the single disease of diabetes. After the integration, Zhiyun Group will include a handheld sugar medicine focused on out-of-hospital management, Zhiyun Medical Center focusing on in-hospital management, and a medical e-commerce country.
In addition, people familiar with the matter said that Zhiyun Health signed a cooperation agreement with Tianyi Investment, a listed company in China, which is a domestic health checkup company. Zhiyun Health will build health services based on more than 400 medical check-up centers under the US Health Care Line. closed loop.
Usually, the traditional medical examination in our country is more of a "one-off" job: sending a medical report to the medical examiner or adding a diet, exercise prescription, there is no more. Substantial follow-up cannot be done for the health checker's more or less health risks.
It is reported that in the provision of chronic disease management services following the medical examination, Zhiyun Health will take targeted measures to prevent and treat related chronic diseases. This also means that every healthy and healthy user will receive a chronic disease risk solution provided by Zhiyun Health after completing the medical examination.
Yu Rong, Chairman of Tianyi Investment Group and Mei Nian Health, said: "Investing in Zhiyun Health is an industrial idea that has emerged in response to the industry's pain points in post-testing chronic disease management and eased the imbalance of quality medical resources. China's preventive medicine is a useful attempt to obtain more professional and comprehensive health services in post-inspection extension, accurate assessment, intelligent diagnosis, and chronic disease management. It is in line with the development strategy of the US health care from a single professional medical institution to a comprehensive medical service organization. ."
According to public information, by 2020, China's 65-year-old population will exceed 160 million. Old age chronic diseases and chronic diseases have shown a clear upward trend. Chronic diseases not only endanger the health of patients, but also cause serious resource consumption for family social burdens and national medical insurance control fees. The incidence of many chronic diseases is not the most "thorny" part, but a complication. Taking diabetes as an example, long-term blood sugar increases damage to large blood vessels and microvessels and endangers the heart, brain, kidney, peripheral nerves, eyes, and feet.
Faced with the thorny management of chronic diseases, Zhiyun Health CEO Yan Ming believes that the management of chronic diseases should adopt an upstream strategy, which is about to move forward. Therefore, providing comprehensive treatment and management for the health management of chronically at-risk populations is also an important direction for Zhiyun Health's next phase of business development.
There are many players in the field of chronic disease management, but data islands are still the pain point of the industry. The scientific research and clinical value can not be really stimulated, and the industry has not yet been a "unicorn". The cooperation with many organizations is conducive to Zhiyun Health to improve the layout of its big data, and it also means that Zhiyun Health extends from the management of chronic diseases to the rear of the industrial chain. According to public information, Zhiyun Health had cooperated with insurance companies in the early years, and after the financing last year, it also hit the “card†of the starting hospital. Now, the non-stop cut into the medical examination institution can also see that Zhiyun has expanded its entire industrial chain. Ambition.
From the physical examination, the service market after the slow-onset examination also means that Zhiyun Health has truly become a health management company, and has been separated from the shadow of “hand-held sugar medicineâ€. It’s not easy to survive in the battlefield of the Sugar Race. It’s the first to break into this segment where the player hasn’t “flowered everywhereâ€. Will Zhiyun’s healthy road go well?
Time Attendance,Time Attendance Software,Face Recognition Attendance,Card Recognition Time Attendance
Shenzhen Bio Technology Co., Ltd , https://www.hfsecuritytech.com